The role of the sFRP4 protein in modulation of cancer growth and anti-neoplastic drug sensitivity
MetadataShow full item record
This project found that reintroducing a regulatory protein, sFRP4, to mesothelioma cancer cell models could inhibit their growth, ability to migrate and induce a form of cell death. In addition sFRP4 could sensitise mesothelioma cells to drug treatment. The mechanisms involved were studied in detail and the project provided new insights into the functions of this protein including identifying the protein structures involved in these effects and its role in cancer cells.
This thesis is unavailable until 04 06 2018
Showing items related by title, author, creator and subject.
Lim, Raelene (2003)Myeloid Leukemia Factor 1 (Mlf1) is the murine homolog of MLF1, which was identified as a fusion gene with Nucleophosmin (NPM) resulting from the (3;5)(q25.1;q34) translocation associated with acute myeloid leukemia and ...
Molecular mechanism underlying aberrant expression of the connective tissue growth factor in paediatric pre-B cell acute lymphoblastic leukemiaWelch, Mathew D. (2011)Acute lymphoblastic leukaemia (ALL) is the most common cancer diagnosed in children aged 1-14 years. There have been vast improvements in clinical outcomes for children diagnosed with ALL with cure rates of up to 90% ...
Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease riskTakechi, Ryusuke (2010)It has been reported that lifestyle including diet is associated with Alzheimer’s disease (AD) risk and progression. Population studies indicate that the chronic consumption of diets enriched in saturated fats (SFA) and ...